Novira Therapeutics Inc. is an antiviral drug discovery company that is focused on the discovery of first-in-class antiviral therapeutics for the treatment of chronic HBV and HIV infections, two global diseases with high levels of unmet need. Novira's oral drugs target the capsid of the virus, and offer a promising treatment option both as monotherapy and in combination with current standards of care.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/24/12 | $23,000,000 | Series A |
5AM Ventures Canaan Partners WuXi PharmaTech | undisclosed |
| 03/26/13 | $25,000,000 | Series A |
5AM Ventures Canaan Partners Versant Ventures | undisclosed |
